Regeneron Pharmaceuticals
REGN
#117
Rank
C$172.75 B
Marketcap
$1,567
Share price
0.18%
Change (1 day)
40.60%
Change (1 year)

EPS for Regeneron Pharmaceuticals (REGN)

EPS in 2023 (TTM): $50.38

According to Regeneron Pharmaceuticals's latest financial reports the company's current EPS (TTM) is $50.67. In 2022 the company made an earnings per share (EPS) of $54.96 a decrease over its 2021 EPS that were of $103.70.

EPS history for Regeneron Pharmaceuticals from 1996 to 2023

Annual EPS

Year EPS Change
2023 (TTM)$50.38-8.33%
2022$54.96-47%
2021$103.70133.36%
2020$44.4469.13%
2019$26.27-14.44%
2018$30.71100.71%
2017$15.3031.78%
2016$11.6138.96%
2015$8.3672.55%
2014$4.84-17.55%
2013$5.87-44.98%
2012$10.67-422.54%
2011-$3.3192.13%
2010-$1.7249.41%
2009-$1.15-15.84%
2008-$1.37-36.88%
2007-$2.17-9.6%
2006-$2.404.12%
2005-$2.31-323.68%
2004$1.03-135.51%
2003-$2.90-24.38%
2002-$3.8456.35%
2001-$2.46187.3%
2000-$0.85-16%
1999-$1.02177.78%
1998-$0.37-35.71%
1997-$0.57-68.42%
1996-$1.80

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
$19.19-62.13%๐Ÿ‡บ๐Ÿ‡ธ USA
-$5.57-111.00%๐Ÿ‡บ๐Ÿ‡ธ USA
$25.04-50.59%๐Ÿ‡บ๐Ÿ‡ธ USA
$19.11-62.30%๐Ÿ‡บ๐Ÿ‡ธ USA
$5.07-89.99%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
$4.31-91.49%๐Ÿ‡ซ๐Ÿ‡ท France